P2RX7 and depressive disorder: The administration of shRNA targeting lncRNA MSTRG.81401 can inhibit the expression of hippocampal P2X7, reduce pyroptosis and inhibit the release of inflammatory cytokines, thus improving pain and depression-like behaviors in rats with comorbid DNP and MDD.